Global /South Korea /Industrials /Airports & Air Services /078160

MEDIPOST Co., Ltd.

078160

• KRX: 078160 • Delayed

27,900KRW -0.4%

18.20 USD

As of 5 June 2026, MEDIPOST Co., Ltd. has a market cap of $289.67M USD, ranking #18822 globally and #625 in South Korea. It ranks #4349 in the Industrials sector, and #157 in the Airports & Air Services industry.

Global Rank

18822

Country Rank

625

Sector Rank

4349

Industry Rank

157

Key Stats

Market Cap

$289.67MUSD

444.01B KRW

Enterprise Value

$690.0MUSD

1.06T KRW

Revenue (TTM)

$48.05MUSD

73.66B KRW

EBITDA (TTM)

-$40.47MUSD

-62.04B KRW

Net Income (TTM)

-$55.71MUSD

-85.4B KRW

EBITDA Margin

-84%

Profit Margin

-116%

PS Ratio

14.9

PB Ratio

4.4

Company Profile

Country (HQ)

South Korea

Sector

Industrials

Industry

Airports & Air Services

CEO

Won-il Oh open_in_new

Employees

322

Founded

2000

Website

medi-post.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.4%	9.8%	15%	17%	70%	54%	228%	93%	-18%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	078160 메디포스트(주) ISIN: KR7078160009 Shares Out.: Shares Outstanding: 39.086M¹ Shares Float: 29.2M² TV: TradingView: KRX: 078160 SA: Stock Analysis: KRX: 078160 YF: Yahoo Finance: 078160.KS GF: Google Finance: KRX: 078160 BA: Barron's: 078160 MS: Morningstar: XKRX: 078160	27,900 KRW	TV: TradingView: KRX: 078160 SA: Stock Analysis: KRX: 078160 YF: Yahoo Finance: 078160.KS GF: Google Finance: KRX: 078160 BA: Barron's: 078160 MS: Morningstar: XKRX: 078160

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About MEDIPOST Co., Ltd.

MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia. Further, the company develops SMUP-IA-01 to treat osteoarthritis; and SMUP-IV-01 for the treatment of diabetic nephropathy. Additionally, it offers nutritional and dietary supplements under the MOVITA brand name; and CDMO services. The company was founded in 2000 and is headquartered in Seongnam-si, South Korea.

Similar Companies

Industry: Airports & Air Services (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Sebang Co., Ltd. KRX: 004360	$215.74M 330.7B KRW -26%	5.4	South Korea
Chunil Express Co., Ltd. KRX: 000650	$188.53M 288.98B KRW -35%	-	South Korea
Korea Airport Service Co.,Ltd. KRX: 005430	$118.71M 181.96B KRW -59%	4.5	South Korea
SUN KWANG CO.,Ltd. KRX: 003100	$97.87M 150.02B KRW -66%	3.8	South Korea
Dongyang Express Corp. KRX: 084670	$66.81M 102.4B KRW -77%	34.6	South Korea
STraffic Co,. Ltd. KRX: 234300	$66.73M 102.28B KRW -77%	21.4	South Korea

Industry: Airports & Air Services (Global)

Name	Market Cap (USD) diff.	PE	Country
Uber Technologies, Inc. NYSE: UBER	$151.68B 52K%	15.7	United States
Aena S.M.E., S.A. BME: AENA	$41.09B 35.43B EUR 14K%	16.6	Spain
Adani Ports and Special Economic Zone Ltd. NSE: ADANIPORTS	$39.97B 3.83T INR 14K%	28.8	India
Transurban Group ASX: TCL	$31.17B 43.68B AUD 11K%	91.1	Australia
MTR Corporation Ltd. SHEK: 66	$27.15B 212.76B HKD 9K%	14.5	Hong Kong
Central Japan Railway Co. TSE: 9022	$24.29B 3.89T JPY 8K%	7.1	Japan

chevron_leftBack